Investors
About Nephros, Inc.
Nephros is committed to improving the human relationship with water through leading, accessible technology. We provide innovative water filtration products and water-quality education as part of an integrated approach to water safety. Nephros goods serve the needs of customers within the healthcare and commercial markets, offering both proactive and emergency solutions for water management.
As a publicly traded company on the Nasdaq (Nasdaq: NEPH), we consistently demonstrate strong financials, product performance, and value for our shareholders. An unwavering pursuit of enhanced engineering, research, and development, along with superior quality control, positions Nephros as a technology leader and gold standard for medical-grade water filtration.
NASDAQ Stock Symbol: NEPH
CUSIP: 640671400
Headquarters:
380 Lackawanna Place
South Orange, NJ 07079
Transfer Agent:
Vstock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
Phone: (212) 828-8436
Toll-Free: (855) 9VSTOCK
Fax: (646) 536-3179
Email: info@vstocktransfer.com
For help transferring a share certificate into a trust or another name, replacing a lost share certification, or to setup online deliveries of shareholder materials:
Looking for more information?
Meet the Nephros Board of Directors, responsible for assessing the overall direction and strategy for how we improve the human relationship with water.
Robert Banks
Responsible for leading the organization with a clear, set vision, developing a strategy to achieve that vision, and then executing…
Joe Harris
Joe is currently the Midwest, Sales Director at Murj. Previous positions have included East, Areas Sales Director at HeartFlow, Inc.,…
Oliver Spandow
Oliver is currently the Chief Financial Officer, Executive Vice President and a member of the board of directors of IDOC,…
Arthur Amron
Arthur is a partner of Wexford Capital and serves as its General Counsel. He actively participates in various private equity…
